The newsletter is not displayed correctly? Please click here.

Newsletter 11/2010

11 June 2010

[gs]  

Thinking totally different, the same old way!

or: bioMérieux, France & Bob Dylan, revisited

If you do not wish to receive this newsletter anymore, just reply to this mail without any comment and you will be taken off the mailing list.

with eruptive technologies continuously changing the life sciences industry, the need for change remains as high as ever – and accordingly the usual talk about innovation and thinking out-of-the-box remains the fashionable “old wine in new skins” it always has been!

One recent and interesting example that actually combines both aspects, i.e.

1. a real interest in changing the course of thinking about business opportunities;

2. and a sticking to the “usual way” of doing business in a specific country

is bioMérieux.

Just returning from France, where I tried to expand the coverage of French life sciences companies by gene-sensor.com and Mass-Spec-Capital.com, I would like to invite you to take a look at the following quote:

QUOTE STARTS

“[...] We are creating this new Chief Technology Officer position to look at technologies that we have never contemplated before with the goal of bringing major innovation to public health", stated Stéphane Bancel, Chief Executive Officer of bioMérieux. "We are very pleased to welcome Alain, whose experience, leadership and outside-the-box thinking will be invaluable as we reinvent our core technologies to build the diagnostic tools of the future."

Alain Pluquet has a Ph.D. in nuclear physics from Fermilab in the U.S. and the CEA. [...] Mr. Pluquet has worked in the CEA network since 1994. Before joining bioMérieux, he was Head of the Signal and Capturing Technology Department at the CEA LIST (Laboratory for system and technology integration).”

Emphasis added! 

QUOTE ENDS

The quote is from the following press release:

bioMérieux S.A.. (11/3/09). "Press Release: Alain Pluquet’s Appointment". Marcy l’Etoile.

Actually, bioMérieux indeed has been serious about “looking at technologies that bioMérieux never contemplated before” like the following news since November 2009 clearly indicate:

bioMérieux S.A.. (1/7/10). "Press Release: Philips and bioMérieux Announce Partnership to Develop and Market Next-generation Handheld Diagnostic Solutions for Point-of-Care". Amsterdam & Marcy l’Etoile.

bioMérieux S.A.. (4/12/10). "Press Release: bioMérieux Acquires from AnagnosTec Database and Expertise for Rapid Microbial Identification Using Mass Spectrometry". Marcy l’Etoile.

bioMérieux S.A.. (4/21/10). "Press Release: bioMérieux and Knome Sign Startegic Partnership". Marcy l’Etoile & Cambridge, MA.

bioMérieux S.A.. (5/21/10). "Press Release: Shimadzu and bioMérieux Enter into Partnership for Mass Spectrometry Applications in Microbiology". Kyoto & Marcy l’Etoile.

However, the method – including as a cornerstone the appointment of Mr. Pluqet – is partly the “good old” French way. Just take one more look at the quote above with regard to Mr. Pluqet’s former employer! And then please read the following press release issued exactly one month later:

bioMérieux S.A.. (12/3/09). "Press Release: Long-term Strategic Partnership between bioMérieux and the CEA to Develop Innovative Diagnostic Technologies for Infectious Disease Management". Marcy l’Etoile.

So, please allow me just one more quote from the Master himself:

An’ if anbody asks me

“Is it easy to forget?”

I’ll say,

“It’s easily done

just pick anyone

and pretend

that you never have met!”

©2010 by [iito] Business Intelligence


NOTES & DISCLAIMER

Some links are available to subscribers only. As this newsletter is a free service, available to anybody without a contractual agreement, the writer disclaims any liabilities and explicitly advises you, not to use this information for your own business decisions. 

I hope you enjoy reading these lines as much as I have enjoyed writing them!

Thank you.

Marcus Lippold
Dipl.-Oek. (Economist)

[iito] Business Intelligence
Parkallee 24
28209 Bremen
Germany

Phone +49(0)-421-62659 196
Fax +49(0)-700-4-367-367-6
E-mail mlippold@iito.de
Web www.gene-sensor.com

This communication is confidential. If you are not the intended recipient, you should not copy or disclose the message to anyone, but should kindly notify the sender and delete the message.

A project of [iito] Business Intelligence© 2002-2010. Made in Germany.